Ensysce Biosciences Inc. Completes Qualifying Financial Transaction Matching

Ensysce Biosciences Inc. Completes Qualifying Financial Transaction Matching

Filed under: Texas Drug Use

Ensysce will use this additional funding towards the completion of studies required to file an Investigational New Drug application with the FDA and bring SWCNT delivery of siRNA rapidly into clinical development. Carbon nanotubes provide a means to …
Read more on MarketWatch (press release)

 

Increase In The Illegal Use Of The Drug "Bath Salts" In Midland 6/4/12

Filed under: Texas Drug Use

Midland, TX – A Florida man made national headlines for eating the face of a homeless man. Now more focus is being put on a drug called "bath salts", which was found in his system. The drug's use is on the rise among teens.
Read more on KOSA

 

Strontium Validation Completed at Positron's Lubbock, Texas Facility

Filed under: Texas Drug Use

MIT has now generated the necessary data required for its Drug Master File (DMF) and will be submitting its DMF to the FDA shortly. The second validation sample from the ARRONAX Cyclotron Facility in Nantes, France is set for strontium processing later …
Read more on Sacramento Bee

 

The Great 0 Lottery Scam: Texas Lottery pursues bearers of 'previously paid

Filed under: Texas Drug Use

The Texas Lottery Commission had charged her husband with "claiming a lottery prize by fraud," a class A misdemeanor, punishable by up to a year in jail. But that wasn't all. When the couple went to court for Riah's first appearance on the fraud charge …
Read more on Austin Chronicle

 

Ensysce Biosciences Inc. Completes Qualifying Financial Transaction Matching Emerging Technology Funds From The State …
HOUSTON–(BUSINESS WIRE)–Ensysce Biosciences Inc. announced today they have accomplished a $1 million dollar raise, part of which completes the Qualifying Financial Transaction milestone for the State of Texas Emerging Technology Fund (ETF). Funding of up to $1.5 million had previously been approved from the State ETF for the development of single walled carbon nanotube (SWCNT) therapeutics for … Read News

Ensysce Biosciences Inc. Completes Qualifying Financial Transaction Matching Emerging Technology Funds From The State …
Ensysce Biosciences Inc. announced today they have accomplished a $1 million dollar raise, part of which completes the Qualifying Financial Transaction milestone for the State of Texas Emerging Technology Fund . … Read News